CT
TMO icon

Colonial Trust’s Thermo Fisher Scientific TMO Stock Holding History

Colonial Trust’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$652K Sell
1,301
-149
-10% -$71.5K 0.08% 155
2026
Q1 		$713K Buy
1,450
+8
+0.6% +$4.34K 0.1% 148
2025
Q4 		$835K Sell
1,442
-14
-1% -$7.92K 0.11% 137
2025
Q3 		$706K Sell
1,456
-15
-1% -$6.98K 0.1% 153
2025
Q2 		$596K Sell
1,471
-75
-5% -$31.4K 0.09% 163
2025
Q1 		$769K Sell
1,546
-4
-0.3% -$2.17K 0.12% 130
2024
Q4 		$806K Buy
1,550
+53
+4% +$29.1K 0.12% 132
2024
Q3 		$926K Sell
1,497
-87
-5% -$51.5K 0.14% 127
2024
Q2 		$876K Buy
1,584
+21
+1% +$12K 0.15% 113
2024
Q1 		$908K Buy
1,563
+32
+2% +$18K 0.17% 110
2023
Q4 		$812K Buy
1,531
+60
+4% +$29K 0.17% 114
2023
Q3 		$745K Buy
1,471
+7
+0.5% +$3.73K 0.18% 102
2023
Q2 		$764K Buy
1,464
+389
+36% +$210K 0.18% 101
2023
Q1 		$620K Buy
1,075
+13
+1% +$7.33K 0.16% 116
2022
Q4 		$585K Buy
1,062
+37
+4% +$19.6K 0.16% 116
2022
Q3 		$520K Buy
+1,025
New +$574K 0.17% 121

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Colonial Trust's TMO Position: Q2 2026 in Review

Colonial Trust reduced its Thermo Fisher Scientific (TMO) stake by 10% in Q2 2026, selling an estimated $71.5K and leaving 1,301 shares worth $652K. The position accounts for 0.08% of the portfolio, ranked #155.

Colonial Trust first reported a position in TMO in Q3 2022 and has held it in 16 quarters since. The position peaked at $926K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Colonial Trust held 1,301 shares of Thermo Fisher Scientific worth $652K as of Q2 2026.
  • Colonial Trust sold 149 Thermo Fisher Scientific shares in Q2 2026, an estimated $71.5K.
  • Thermo Fisher Scientific made up 0.08% of Colonial Trust's portfolio in Q2 2026, its #155 holding.
  • Colonial Trust first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 16 quarters since.
  • Colonial Trust's Thermo Fisher Scientific position peaked at $926K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.